Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Féger

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococciR Auckenthaler, P Courvalin, C Féger, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibioticsJ Vouillamoz, J M Entenza, C Féger, et al.
Journal De Radiologie|February 18, 2006
[Juvenille papillomatosis]L Fellah, C Féger, M Berlière, et al.
Radiology|August 1, 1994
Focal areas of increased opacity in ductal carcinoma in situ of the comedo type: mammographic-pathologic correlationK Kinkel, R Gilles, C Féger, et al.
BMC Infectious Diseases|September 15, 2021
The impact of comorbidities and their stacking on short- and long-term prognosis of patients over 50 with community-acquired pneumoniaE Blanc, G Chaize, S Fievez, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococciR Auckenthaler, P Courvalin, C Féger, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibioticsJ Vouillamoz, J M Entenza, C Féger, et al.
Journal De Radiologie|February 18, 2006
[Juvenille papillomatosis]L Fellah, C Féger, M Berlière, et al.
Radiology|August 1, 1994
Focal areas of increased opacity in ductal carcinoma in situ of the comedo type: mammographic-pathologic correlationK Kinkel, R Gilles, C Féger, et al.
BMC Infectious Diseases|September 15, 2021
The impact of comorbidities and their stacking on short- and long-term prognosis of patients over 50 with community-acquired pneumoniaE Blanc, G Chaize, S Fievez, et al.
Pageof 1